🩸 Today's case-based questions!
The first question focuses on molecular risk in CMML using CPSSmol.
The second question focuses on HMA resistance in CMML.
Swipe to see the answers and explanations!
#CMML #Hematology #HemeOnc #SRSF2 #ASXL1 #TET2 #HEMEHUB #MedEd #HemeCases #ClinicalHematology
🩸Additional facts about disease biology & pathogenesis in Chronic Myelomonocytic Leukemia
#CMML #Hematology #Leukemia #HemeOnc #MedicalEducation #HematologyEducation #MyeloidBias #SRSF2 #ASXL1 #RAS #Inflammasome #NLRP3 #Cytokines #IL1beta #IL18 #MedEd #HEMEHUB
Don’t just attend #ASH26, help shape it.
Apply to lead a 2026 Scientific Workshop and guide an interactive discussion on emerging data and scientific discoveries in a particular field of hematology. https://ow.ly/LHVI50YEwJ8
#Hematology #HemeOnc
🌐Enhance your hematology knowledge with HemeHub webinars, available anytime.
All past sessions are organized by topic directly on our website and are also available on YouTube.
🔗 Learn more at hemehub.org
#HemeHub #Hematology #HemeEd #HemeOnc #BMF #Lymphoma #BleedingDisorders #ThromboticDisorders
We’re going live in 1 hour! ⏰ Join Amir Ali, PharmD, BCOP and James Davis, PharmD, BCOP at 7 PM EDT. Get practical tips on bispecific antibody dosing, administration & toxicity management. Register: https://bit.ly/NHLVirtual26-Sky
#HOPA2026 #HemeOnc
Happening this Friday!
🔗Register: hemehub.org/live-webinars
🔗Submit your cases: hemehub.org/case-submiss...
#CMML #Hematology #HematologyEducation #BloodDisorders #Leukemia #MedEd #HemeOnc #ClinicalCases #PatientCases #BloodCancer #HEMEHUB
@mayoclinic.org @clevelandclinic.bsky.social
🩸Today’s questions!
Swipe to see the answers and their explanations.
#Hematology #ClinicalHematology #Myelofibrosis #PolycythemiaVera #MyeloproliferativeNeoplasms #MPN #PostPVMF #BoneMarrowDisorders #Splenomegaly #Leucoerythroblastosis #HemeOnc #MedEd #HemeHub #ACVR1 #ALK2
🩸 Advancing hematology through expert-led, case-based learning and clinical collaboration.
🔗Case submissions: hemehub.org/case-submiss...
🌐 Explore more: hemehub.org
#Hematology #ClinicalHematology #HemeOnc #MedEd #MedicalEducation #CaseBasedLearning #HemeHub
Happening on Friday!
🔗Register: hemehub.org/live-webinars
🔗Submit your cases: hemehub.org/case-submiss...
#CMML #Hematology #HematologyEducation #BloodDisorders #Leukemia #MedEd #HemeOnc #ClinicalCases #PatientCases #BloodCancer #HEMEHUB
@mayoclinic.org @clevelandclinic.bsky.social
Shoutout to Drs. Gay & Quinn for leading an amazing discussion at #HOPA2026 yesterday! We’re not done yet 👀 Join us today at 7AM CDT & Friday at 12PM CDT–in New Orleans or virtually. Plus live virtually 3/31–4/2 ➡️ https://bit.ly/HOPA2026
#CME #MedEd #HemeOnc
Applications are now open to lead a 2026 Scientific Workshop at #ASH26!
This is your opportunity to organize an interactive workshop highlighting recent data and scientific discoveries in a particular field of hematology.
Apply today: https://ow.ly/IlC350YwXBX
#HemeSky #HemeOnc #MedSky
🩸🔬Today’s questions!
The first question reviews key features distinguishing "prefibrotic" #PMF from #ET.
The second question focuses on targeted therapy for #anemia in MF.
Swipe to see the answers and their explanations!
#Myelofibrosis #PrefibroticPMF #MPN #Hematology #HemeOnc #MedEd #HemeHub
🩸 Additional insights on combination & emerging therapies in Myelofibrosis
#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #HEMEHUB #Luspatercept #PIM1 #Nuvisertib #TP3654 #Ruxolitinib #Momelotinib #Imetelstat #TregTherapy #Immunotherapy
🩸Committed to advancing hematology education together by delivering accessible, clinically relevant knowledge.
#Hematology #HemeOnc #MedEd @ash.hematology.org @htrstoday.bsky.social @rarediseasectn.bsky.social @rarediseasesint.bsky.social @rarediseaseadvisor.bsky.social @texasoncology.bsky.social
🩸Today’s questions!
Swipe to see the answers and their explanations.
#Myelofibrosis #MF #Hematology #HemeOnc #HematologyEducation #MedEd #MedicalEducation #ClinicalTrials #JAKInhibitors #Momelotinib #Ruxolitinib #SIMPLIFY1 #ASH #HemeHub @ash.edu.hematology.org @ash.hematology.org
🩸Facts about Myelofibrosis:
Combination & Emerging Therapies
#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #Epigenetics #Pelabresib #Ruxolitinib #JAKInhibitors #Selinexor #NFkB #Cytokines #HemeHub #HematologyEducation #MedicalEducation
🩸💡 Practical hematology education through focused case discussions designed to support real-world clinical decision-making.
🌐 Learn more: hemehub.org
#HemeHub #Hematology #HemeOnc #MedEd #ClinicalLearning
🩸🔬Today’s question!
Swipe to see the answer and its explanation!
#Myelofibrosis #MF #Hematology #HemeOnc #Hepcidin #JAKSTAT #Erythropoiesis #MPN #BloodDisorders #HematologyEducation #MedEd #HemeHub #ClinicalHematology #PatientCare @gmpnsf.bsky.social
🩸 Additional insights on JAK inhibitor therapy in myelofibrosis
#Myelofibrosis #MF #Hematology #HemeOnc #JAKInhibitors #Momelotinib #Ruxolitinib #Fedratinib #Pacritinib #Thrombocytopenia #Platelets #JAKiDiscontinuation #ClinicalTrials #SIMPLIFY2Trial #MedEd #BloodDisorders #MPN #HEMEHUB
🌐🩸 Dedicated to supporting hematology education through accessible knowledge and clinical expertise.
Learn more: hemehub.org
#Hematology #HemeOnc #MedEd #HemeHub #TexasOncology #UPA #WhiteTulipHealthFoundation @ash.edu.hematology.org @isbt.bsky.social @bsochaem.bsky.social @htrstoday.bsky.social
📢 Applications now open! ASH is collaborating with the U.S. Food and Drug Administration for an exclusive workshop on regulatory science in #hematology!
Apply now and be part of this essential conversation: https://ow.ly/H4Lq50Yr3rq
#Hemesky #Medsky #hemeonc
🩸Today’s questions!
Swipe to see the answers and their explanations!
#Myelofibrosis #MPN #Hematology #HemeOnc #Ruxolitinib #Selinexor #Pelabresib #JAKInhibitors #Hepcidin #Erythropoiesis #Splenomegaly #BoneMarrow #BloodDisorders #MedEd #ClinicalHematology #MPNResearch #BloodCancer #HEMEHUB
🩸Facts about Myelofibrosis:
JAK Inhibitor Therapy
#Myelofibrosis #MPN #Hematology #JAKInhibitors #Ruxolitinib #Momelotinib #ACVR1 #Hepcidin #Erythropoiesis #Splenomegaly #BoneMarrow #BloodDisorders #ClinicalHematology #MedEd #HemeOnc #HEMEHUB
@gmpnsf.bsky.social @rarediseaseadvisor.bsky.social
🩸Today’s question focuses on managing anemia in a patient with myelofibrosis who develops transfusion dependence during treatment.
See the answer and explanation on the next slide!
#Myelofibrosis #PMF #MPN #Hematology #HemeOnc #Ruxolitinib #Momelotinib #Anemia #MedEd #MedicalEducation #HemeHub
🩸Additional insights into disease pathogenesis and diagnosis in Myelofibrosis
#Myelofibrosis #PrimaryMyelofibrosis #Hematology #MPN #HemeOnc #MedEd #BoneMarrow #Anemia #Neutrophils #BloodDisorders #HemeTwitter #HemeHub
@mpnjournal.bsky.social @gmpnsf.bsky.social @rarediseaseadvisor.bsky.social
🌍 Expanding access to #hematology education through shared knowledge and clinical insights.
Learn more: hemehub.org
#HemeOnc #MedEd #HemeHub #TexasOncology #UPA #WhiteTulipHealthFoundation
@bsochaem.bsky.social @isbt.bsky.social @ash.edu.hematology.org @ash.hematology.org
🩸Today’s question focuses on the clinical impact of ruxolitinib plus pelabresib in newly diagnosed primary myelofibrosis.
See the answer and explanation on the next slide!
#Myelofibrosis #PMF #Hematology #JAK2 #Ruxolitinib #Pelabresib #ClinicalTrials #HemeOnc #MedicalEducation #HemeHub
🩸 Advancing hematology through expert-led, case-based discussions.
➡️ Case submissions: hemehub.org/case-submiss...
🌐 Explore more: hemehub.org
#Hematology #ClinicalHematology #HemeOnc #MedEd #MedicalEducation #CaseBasedLearning #HemeHub
Clinical Snapshot: #DLBCL QoL Reporting 📊
• Data: Clinicians underreport symptoms vs patients (Kappa 0.16–0.44).
• Impact: Leads to inaccurate risk assessments.
From @bloodjournals.hematology.org. Read: https://bit.ly/4u2XCuL
#HemeOnc #lymsm
🩸 Additional insights on myeloma biology and microenvironment
#MultipleMyeloma #EquilibriumPhase #Immunotherapy #HEMEHUB #EscapePhase #PD1 #CTLA4 #BCells #HemeOnc #Hematology
